<DOC>
	<DOCNO>NCT01463813</DOCNO>
	<brief_summary>The Finnish Vitamin D Trial ( FIND ) randomize , double-blind , placebo-controlled , 5-year supplementation study benefit risk vitamin D primary prevention cardiovascular ( CVD ) cancer among 18000 men 60 year old woman 65 year old . [ Edit 25.3.2015 : Due difficulty recruitment funding , study size approximately 2500 subject , 550 subject subgroup detail examination ] The participant randomize 3 group 6000 , daily supplementation either : 1 ) 40 µg/day ( 1600 IU ) vitamin D3 , 2 ) 80 µg/day ( 3200 IU ) vitamin D3 , 3 ) placebo . [ Edit 15.3.2015 : The 2500 subject randomize 3 group , approximately 830 subject per group . ] Compliance , use non-study drug supplement , diet , development endpoint , CVD cancer risk factor assess questionnaire . Blood sample collect assessment effect modification baseline 25-hydroxyvitamin D , well future ancillary study genetic/biochemical hypothesis . Event data obtain record linkage national computerized hospitalization registry .</brief_summary>
	<brief_title>Finnish Vitamin D Trial ( FIND )</brief_title>
	<detailed_description>More detailed description available upon request .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Bone Density Conservation Agents</mesh_term>
	<criteria>Men 60 year old Women 65 year old Cardiovascular disease ( include myocardial infarction , stroke , transient ischemic attack , angina pectoris , coronary artery bypass grafting , percutaneous coronary intervention ) . Cancer ( except nonmelanoma skin cancer ) . Any disease state raise vitamin D relate safety concern ( chronic liver , thyroid kidney disease , hypercalcemia , sarcoidosis granulomatous disease active chronic tuberculosis Wegener 's granulomatosis ) . Use supplement yield vitamin D 20 µg/day calcium 1200 mg/day unwillingness discontinue use .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>bone density conservation agent</keyword>
	<keyword>cancer</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>cholecalciferol</keyword>
	<keyword>diabetes mellitus , type 2</keyword>
	<keyword>dietary supplement</keyword>
	<keyword>primary prevention</keyword>
	<keyword>vitamin D</keyword>
</DOC>